bioAffinity to showcase CyPath Lung cancer test at Society for Advanced Bronchoscopy webinar

bioAffinity Technologies announced a June 16 webinar featuring physicians discussing real-world benefits of its noninvasive CyPath Lung test for early-stage lung cancer detection. The event highlights the test's clinical utility in reducing unnecessary invasive procedures and supporting cancer surveillance.